CANY
CNCE

Caxton Associates (New York)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Caxton Associates (New York)’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-83,993
Closed -$491K – 666
2022
Q4 		$491K Sell
83,993
-40,122
-32% -$234K 0.03% 225
2022
Q3 		$832K Buy
+124,115
New +$832K 0.11% 137